Out of the twelve patients whose medication regimens were modified following infection, nine required the addition of new medications, including IVIG and steroids (n = 3), steroids alone (n = 2), tacrolimus (n = 1), corticosteroid–mycophenolate combination (n = 1), and acetylcholinesterase inhibitors (n = 2). The gene discussed is ACHE; the disease is infection.